The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), Egypt’s Minapharm, and its Berlin-based subsidiary, ProBioGen AG, announce the agreement to produce in Egypt, first registered vaccine against COVID-19, Sputnik V.
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), Egypt’s Minapharm, and its Berlin-based subsidiary, ProBioGen AG, announce the agreement to produce in Egypt, first registered vaccine against COVID-19, Sputnik V.